As reported by WLOS News 13, arrest warrants allege the owner of Blackford Wellness used forged prescription information while diagnosing clients and prescribing and distributing tirzepatide during five transactions in 2025.
Wellness Business Owner Faces Allegations of Unlicensed GLP-1 Prescribing
On July 13, 2026, WLOS News 13 reported that the owner of an Asheville wellness business was charged with 10 felony offenses alleging the unauthorized diagnosis, prescribing, and distribution of tirzepatide without a North Carolina medical license. The reported case is relevant to Med Spa and wellness operators, involving allegations related to prescribing authority, provider credentials, and the lawful distribution of prescription GLP-1 medications.
Reported Felony Charges Involve Alleged Unauthorized Tirzepatide Prescribing and Distribution
WLOS News 13 reported on July 13, 2026, that Priscilla Ann Hendrix, owner of Blackford Wellness in Asheville, North Carolina, faces 10 felony charges stemming from allegations that she diagnosed clients and prescribed and distributed tirzepatide without a North Carolina medical license. The news outlet stated the alleged conduct involved five transactions with two clients between July and September 2025.
Key reported details of the allegations include:
- Scope of the felony charges: The report states Hendrix was charged with five counts of practicing medicine without a North Carolina license and five counts of obtaining property by false pretenses.
- Alleged prescribing activity: Investigators allege Hendrix diagnosed clients and prescribed and distributed tirzepatide, a prescription GLP-1 medication used to treat diabetes and obesity, during five separate transactions.
- Prescription information: The report states investigators allege the prescription information either identified Hendrix as a certified nurse practitioner or used the name of another nurse practitioner as the medical provider.
- Reported transactions: The allegations involve two clients and five payments ranging from $195 to $255, totaling $1,095.
- Medication source and provider knowledge: The news outlet reported the available court documents do not explain where the tirzepatide originated or whether the nurse practitioner whose name allegedly appeared on the prescription information knew their credentials were being used.
Court records cited by WLOS News 13 indicate all 10 felony charges remain pending. The outlet also reported Hendrix was arrested on July 8, 2026, during a traffic stop, released after posting a $60,000 secured bond later that day, and is scheduled to appear for a disposition hearing on September 17, 2026.
Source Publication
According to the July 13, 2026, WLOS News 13 report, last updated July 15, 2026, the article examines criminal charges filed against Priscilla Ann Hendrix, owner of Blackford Wellness in Asheville, North Carolina. The report covers allegations involving the unauthorized diagnosis, prescribing, and distribution of tirzepatide and references information from arrest warrants, court records, and the Buncombe County Sheriff’s Office.
North Carolina GLP-1 Compliance Considerations for Med Spa and Wellness Operators
The allegations reported in this case involve compliance areas that have also appeared in other regulatory actions involving GLP-1 medications, including prescribing authority, provider documentation, and prescription drug oversight.
Prescribing Authority
The reported allegations involve the diagnosis, prescribing, and distribution of tirzepatide without a North Carolina medical license. Similar allegations involving GLP-1 prescribing, compounding, and recordkeeping were raised in a California Medical Board proceeding involving semaglutide and tirzepatide.
Provider Documentation
The report also alleges prescription information identified either the business owner or another healthcare provider during the reported transactions. Provider identification and clinical documentation have likewise been examined in GLP-1 enforcement matters, including the Connecticut Attorney General’s GLP-1 settlements involving a Med Spa and an online platform.
Prescription GLP-1 Oversight
Federal regulators have also taken action involving GLP-1 business practices through the FDA’s warning letters addressing certain online promotion and prescribing-related representations for compounded GLP-1 medications.
Recent regulatory and enforcement actions have involved prescription GLP-1 medications across multiple jurisdictions. The reported allegations involve the alleged unlicensed practice of medicine and prescribing in North Carolina, which fall under the authority of the North Carolina Medical Board.
Practical and Operational Considerations for Med Spa and Wellness Operators
- Verify prescribing authority for practitioners involved in prescribing prescription GLP-1 medications.
- Confirm provider credentials associated with prescription records and patient documentation.
- Maintain accurate clinical records supporting prescription medication services.
- Review GLP-1 prescribing workflows for consistency with applicable state requirements.
- Audit prescription documentation to ensure provider information is accurately reflected in patient records.
What to Watch Next
WLOS News 13 reported that the criminal charges remain pending, with a disposition hearing scheduled for September 17, 2026. Future court proceedings or announcements from North Carolina authorities may provide additional information regarding the allegations and the status of the case.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Buncombe County Courthouse 2” by Stilfehler, via Wikimedia Commons, licensed under CC BY-SA 4.0.
